Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Belatacept Dose Reduction Safety in Kidney Transplant Recipients with a Well-Matched Donor

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Austria
  • Molecularly Tailored Therapy Versus Standard Care in Patients With Advanced Pancreatic Cancer Using Olaparib, Erlotinib, Crizotinib, Trametinib, Pemigatinib, Selpercatinib, Axitinib, Vismodegib, Pembrolizumab, Larotrectinib, Dabrafenib, Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan, Gemcitabine, Paclitaxel Albumin-Bound, and Calcium Folinate

    Not yet recruiting

    2 1 1 1
    Denmark
  • Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy

    Not yet recruiting

    2 1 1
    Investigated diseases:
    France
  • Maribavir for High Epstein-Barr Virus Infection in Young Adult Kidney Transplant Recipients

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Verteporfin for Scar Prevention in Patients After Surgical Wounds

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Denmark
  • DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors

    Not yet recruiting

    2 1 1
    France Germany Italy Poland Spain
  • Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma After Second-Line Platinum-Based Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Italy
  • Vasopressin Versus Norepinephrine for Patients with Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy Surgery

    Not yet recruiting

    3 1 1 1
    France
  • Venetoclax Added to Standard Chemotherapy and Midostaurin for Patients with FLT3-Mutated Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Lerodalcibep for Heterozygous Familial Hypercholesterolemia in Children and Adolescents 6 to 17 Years Old

    Not yet recruiting

    3 1
    Investigated drugs:
    Norway